Our Journey

Everyone wants to understand their DNA

But too few have access to reliable, clinically meaningful testing, clear and simple reports, and follow-up care from trusted health professionals, all at a cost that feels truly within reach. We’re here to change that.

We’ve been part of the genetics journey since the human genome was first decoded back in 2000. Our team has spent years helping doctors, families, and communities understand genetic testing and what the results really mean.

More, we are using AI, alongside human expertise, to help turn complex genetic data into reports that regular people can actually understand. We focus on explaining things in a meaningful, down-to-earth way, so families can use the information to take better care of their health and plan for the future.

About Us

Modal Nova

stands for

Genome Modality Innovations

Reflecting our commitment to advancing precision health through integrative multi-omic, point-of-care and AI technologies

For professionals: At Nova, we are pioneering a multimodal approach that combines genomic and proteomic analytics, with AI-driven insights to enhance the interpretability of DNA-based care.

For patients: That means we’re using advanced tools - including your DNA data and health information, plus smart AI, to make genetic test results more useful and easier to understand.

Our platform delivers clinically relevant interpretations at the point of care to primary care providers, with clear, accessible summaries and readings for patients and their families.

By bridging complex biological data with real-world clinical relevance, Nova aims to redefine how genomic medicine is delivered at scale.

Bridging the last mile in genomics

Advancing
Autism Spectrum Disorder
Genetic Diagnosis

Specialist in Neurodevelopmental Health

Autism spectrum disorder often runs in families (highly heritable). Many children with autism also have other challenges, like delays in speaking or learning, intellectual disability, or epilepsy (comorbidities).

At Nova, our goal is to use advanced genetic testing (called whole genome sequencing) to find answers that can help.

A genetic diagnosis may guide treatment, help predict how the condition may develop, and sometimes even allow doctors to choose treatments that work better for the child (personalized medicine).

Explore More

Empowering Parents to be the Most Powerful Part of ASD Treatment

Parental education is important because parents spend the most time with their child. If they learn how to support their child with autism - like how to talk, manage behavior, and help them learn, it can make a big difference.

Sometimes, autism is linked to changes in certain genes. Some autism-related genes can lead to different symptoms. Some show up early, others may appear as the child grows. That’s why it’s important for parents to keep an eye on changes over time.

At Nova, we provide easy-to-understand genetic reports for parents. When results are explained in plain language, it helps parents understand what the findings mean. This way, they can notice new signs sooner and give the support their child needs at the right time - like therapy, learning, or daily care, based on the child’s unique condition.

Breast & Prostate
Cancer Prevention
Unmodifiable Genetic Risk Assessment

Specialist in Cancer Prevention

Some cancers, like prostate and breast cancer, can be linked to changes in our DNA.

There are two kinds of changes we look at: monogenic and polygenic. Monogenic means a single gene change, like BRCA1 or BRCA2, which can greatly increase your cancer risk.These are rare but serious. Polygenic means many small changes in different genes that, when added together, can also raise your risk.

By looking at both types of changes, we get a better idea of your chance of developing cancer.

With the right timing and approach, this kind of personalized screening can make a real difference - and even save lives.

Breast Cancer

BRCA1 and BRCA2 are well-known genes linked to breast cancer, but many women who develop breast cancer don’t have changes in these two genes. In fact, there are many other genes - like PALB2, CHEK2, and others - that can also raise the risk. If we only test two genes, we might miss important warning signs.

In addition to those rare but high-risk gene changes, many small DNA changes (polygenic) can add up and affect a woman’s chance of getting cancer, too.

Understanding both rare high-risk gene mutations and these more common small changes means we can better identify women who are at higher risk, even if they have no family history.

That means finding cancer sooner, when it’s easier to treat, and before it spreads. Early screening, guided by the right genetic information, can save lives.

Prostate Cancer

If a man has an elevated PSA level, it might be a sign of prostate cancer - but it can also be caused by something less serious, like a non-cancerous enlarged prostate.

To better understand the risk, genetic testing can help show if there are certain gene changes that make someone more likely to develop prostate cancer - especially the more aggressive kind, that can spread to other parts of the body.

This kind of testing gives clearer answers and can help guide early and more personal care.